Pharmacy Solutions have compiled recent Androgenetic alopecia (AA) research and coupled the results of various ingredients with cutting edge drug delivery technology to provide a foam that addresses the multiple influences of hair loss.
The formulation is, in essence, a mild cosolvent system that evaporates after application, thereby transforming into a myriad of flexible vesicles that wrap the active ingredients in a phospholipid/ethanol/surfactant composite to help drive the ingredients into the skin and hair follicles. Vesicle formation was confirmed via light microscopy (1000x) and this particular delivery system has provided a significant advantage in the transport of numerous pharmaceuticals into and through the skin. In summary, our new foam formulation is elegant, formulated with EWG class (1-3) excipients, propellant free, and addresses the shortcomings of the older commercial formulations by incorporating contemporary research in androgenetic alopecia, and topical drug delivery as well.
Formulation: Minoxidil 2%, Caffeine 0.5%, Levocetirizine 0.5% foam
Directions: Massage 1-2 pumps of foam into affected areas of scalp twice daily. If possible, moisten scalp before applying.
Side effects: Redness, transient burning/irritation are possible.
Allergy warnings: Avoid if allergic to soy products. Also avoid if patient had hypersensitivity reaction to minoxidil, levocetirizine (or cetirizine), or caffeine previously.
Quantity: 60mL
Healthcare professionals realize that commercially available medications are limited or at times are unable to meet unique patient needs. Pharmacy Solutions cooperates with practitioners of every medical discipline, to customize (i.e. compound) strengths and delivery methods of medications needed to treat patients individually.